Immunodeficiency, Centromeric Instability, and Facial Dysmorphism (ICF) Syndrome: How HSCT alters the impairment of the DNA methylation process
Introduction and purpose In 2024, the EBMT Inborn Errors Working Party published a study that confirmed the beneficial role of hematopoietic stem cell transplantation (HSCT) in patients with immunodeficiency, centromeric instability, and facial dysmorphism (ICF) syndrome. In this article, we aim to...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Kazimierz Wielki University
2025-02-01
|
| Series: | Journal of Education, Health and Sport |
| Subjects: | |
| Online Access: | https://apcz.umk.pl/JEHS/article/view/57736 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1823856502215016448 |
|---|---|
| author | Wojciech Homa Joanna Wanat Izabela Dzikowska Agata Siejka Daria Stefaniak Aleksandra Warunek Gabriela Gronowicz Michał Chról Weronika Zielińska |
| author_facet | Wojciech Homa Joanna Wanat Izabela Dzikowska Agata Siejka Daria Stefaniak Aleksandra Warunek Gabriela Gronowicz Michał Chról Weronika Zielińska |
| author_sort | Wojciech Homa |
| collection | DOAJ |
| description |
Introduction and purpose
In 2024, the EBMT Inborn Errors Working Party published a study that confirmed the beneficial role of hematopoietic stem cell transplantation (HSCT) in patients with immunodeficiency, centromeric instability, and facial dysmorphism (ICF) syndrome. In this article, we aim to present the characteristics of ICF in an accessible way, including its genetic background, clinical presentation, immunological alterations, and treatment options.
A brief description of the state of knowledge
In recent years, published reviews and series of cases have expanded the range of known symptoms and complications occurring in patients with ICF. Our understanding of immunological alterations in ICF evolved from isolated defects of immunoglobulin production to a comprehensive model, which involves impairment of cellular immunity. Advances in molecular biology and genetics enabled insights into the DNA methylation machinery, which allowed us to gain a more precise understanding of the pathogenesis of ICF and also opened up opportunities for the development of new therapeutic options.
Summary
Inborn errors of immunity (IEI), such as ICF, are diagnosed at an early stage of life. It enables effective treatment with longer survival of the patients. It means that healthcare professionals are increasingly likely to encounter such patients in their clinical practice. Thus, it is crucial to inform about the usage of the HSCT in ICF syndrome and spread awareness of potential new treatment options, that may emerge in the near future.
|
| format | Article |
| id | doaj-art-6d8989226fa14b499612d32b966bf12c |
| institution | Kabale University |
| issn | 2391-8306 |
| language | English |
| publishDate | 2025-02-01 |
| publisher | Kazimierz Wielki University |
| record_format | Article |
| series | Journal of Education, Health and Sport |
| spelling | doaj-art-6d8989226fa14b499612d32b966bf12c2025-02-12T08:17:47ZengKazimierz Wielki UniversityJournal of Education, Health and Sport2391-83062025-02-017810.12775/JEHS.2025.78.57736Immunodeficiency, Centromeric Instability, and Facial Dysmorphism (ICF) Syndrome: How HSCT alters the impairment of the DNA methylation processWojciech Homa0https://orcid.org/0000-0003-2177-8818Joanna Wanat1https://orcid.org/0009-0009-3349-3618Izabela Dzikowska2https://orcid.org/0009-0006-5539-3771Agata Siejka3https://orcid.org/0009-0009-2332-0115Daria Stefaniak4https://orcid.org/0009-0002-2207-4177Aleksandra Warunek5https://orcid.org/0009-0000-7542-6522Gabriela Gronowicz6https://orcid.org/0009-0009-4034-1284Michał Chról7https://orcid.org/0009-0005-7776-6260Weronika Zielińska8https://orcid.org/0009-0007-0707-9590Wojewódzki Szpital Specjalistyczny. al. Kraśnicka 100, 20-718 Lublin, Poland. Medical University of Lublin. Aleje Racławickie 1, 20-059 Lublin, Poland.Medical University of Lublin. Aleje Racławickie 1, 20-059 Lublin, Poland.Medical University of Lublin. Aleje Racławickie 1, 20-059 Lublin, Poland.Medical University of Lublin. Aleje Racławickie 1, 20-059 Lublin, Poland.Medical University of Lublin. Aleje Racławickie 1, 20-059 Lublin, Poland.Medical University of Lublin. Aleje Racławickie 1, 20-059 Lublin, Poland.Medical University of Lublin. Aleje Racławickie 1, 20-059 Lublin, Poland.Medical University of Lublin. Aleje Racławickie 1, 20-059 Lublin, Poland. Introduction and purpose In 2024, the EBMT Inborn Errors Working Party published a study that confirmed the beneficial role of hematopoietic stem cell transplantation (HSCT) in patients with immunodeficiency, centromeric instability, and facial dysmorphism (ICF) syndrome. In this article, we aim to present the characteristics of ICF in an accessible way, including its genetic background, clinical presentation, immunological alterations, and treatment options. A brief description of the state of knowledge In recent years, published reviews and series of cases have expanded the range of known symptoms and complications occurring in patients with ICF. Our understanding of immunological alterations in ICF evolved from isolated defects of immunoglobulin production to a comprehensive model, which involves impairment of cellular immunity. Advances in molecular biology and genetics enabled insights into the DNA methylation machinery, which allowed us to gain a more precise understanding of the pathogenesis of ICF and also opened up opportunities for the development of new therapeutic options. Summary Inborn errors of immunity (IEI), such as ICF, are diagnosed at an early stage of life. It enables effective treatment with longer survival of the patients. It means that healthcare professionals are increasingly likely to encounter such patients in their clinical practice. Thus, it is crucial to inform about the usage of the HSCT in ICF syndrome and spread awareness of potential new treatment options, that may emerge in the near future. https://apcz.umk.pl/JEHS/article/view/57736Immunodeficiency–centromeric instability–facial dysmorphism (ICF) syndromeInborn Errors of ImmunityHematopoietic stem cell transplantationCombined immunodeficiency |
| spellingShingle | Wojciech Homa Joanna Wanat Izabela Dzikowska Agata Siejka Daria Stefaniak Aleksandra Warunek Gabriela Gronowicz Michał Chról Weronika Zielińska Immunodeficiency, Centromeric Instability, and Facial Dysmorphism (ICF) Syndrome: How HSCT alters the impairment of the DNA methylation process Journal of Education, Health and Sport Immunodeficiency–centromeric instability–facial dysmorphism (ICF) syndrome Inborn Errors of Immunity Hematopoietic stem cell transplantation Combined immunodeficiency |
| title | Immunodeficiency, Centromeric Instability, and Facial Dysmorphism (ICF) Syndrome: How HSCT alters the impairment of the DNA methylation process |
| title_full | Immunodeficiency, Centromeric Instability, and Facial Dysmorphism (ICF) Syndrome: How HSCT alters the impairment of the DNA methylation process |
| title_fullStr | Immunodeficiency, Centromeric Instability, and Facial Dysmorphism (ICF) Syndrome: How HSCT alters the impairment of the DNA methylation process |
| title_full_unstemmed | Immunodeficiency, Centromeric Instability, and Facial Dysmorphism (ICF) Syndrome: How HSCT alters the impairment of the DNA methylation process |
| title_short | Immunodeficiency, Centromeric Instability, and Facial Dysmorphism (ICF) Syndrome: How HSCT alters the impairment of the DNA methylation process |
| title_sort | immunodeficiency centromeric instability and facial dysmorphism icf syndrome how hsct alters the impairment of the dna methylation process |
| topic | Immunodeficiency–centromeric instability–facial dysmorphism (ICF) syndrome Inborn Errors of Immunity Hematopoietic stem cell transplantation Combined immunodeficiency |
| url | https://apcz.umk.pl/JEHS/article/view/57736 |
| work_keys_str_mv | AT wojciechhoma immunodeficiencycentromericinstabilityandfacialdysmorphismicfsyndromehowhsctalterstheimpairmentofthednamethylationprocess AT joannawanat immunodeficiencycentromericinstabilityandfacialdysmorphismicfsyndromehowhsctalterstheimpairmentofthednamethylationprocess AT izabeladzikowska immunodeficiencycentromericinstabilityandfacialdysmorphismicfsyndromehowhsctalterstheimpairmentofthednamethylationprocess AT agatasiejka immunodeficiencycentromericinstabilityandfacialdysmorphismicfsyndromehowhsctalterstheimpairmentofthednamethylationprocess AT dariastefaniak immunodeficiencycentromericinstabilityandfacialdysmorphismicfsyndromehowhsctalterstheimpairmentofthednamethylationprocess AT aleksandrawarunek immunodeficiencycentromericinstabilityandfacialdysmorphismicfsyndromehowhsctalterstheimpairmentofthednamethylationprocess AT gabrielagronowicz immunodeficiencycentromericinstabilityandfacialdysmorphismicfsyndromehowhsctalterstheimpairmentofthednamethylationprocess AT michałchrol immunodeficiencycentromericinstabilityandfacialdysmorphismicfsyndromehowhsctalterstheimpairmentofthednamethylationprocess AT weronikazielinska immunodeficiencycentromericinstabilityandfacialdysmorphismicfsyndromehowhsctalterstheimpairmentofthednamethylationprocess |